solid tumor

An arrow incrementally going up stairs before pointing straight up Blue background
Biotech

Merck KGaA posts tumor data ahead of showdown with Daiichi, Ono

The German drugmaker has shown off data that fueled its $85 million bet on a late-phase treatment for a rare, locally aggressive tumor.
Nick Paul Taylor May 28, 2025 8:45am
Large layoffs of employees Wooden figures of people going to the exit

Boundless Bio lays off 33% of staff as lead program stumbles

May 27, 2025 8:40am
pile of cash piggy bank money cash dollars bills spend

Pathos AI's $365M series D to fund trial of Novo tumor drug

May 15, 2025 10:20am
time minute

Enliven calls time on phase 1 HER2 solid tumor program

May 15, 2025 7:50am
a lot of scissors

Takeda shoots down bispecifics bagged in Maverick buyout

May 8, 2025 8:30am
Blue race track

Relay starts 3rd layoff wave in one year, shedding 70 staffers

Apr 4, 2025 11:30am